InfuSystems Holdings's EPS (Basic) for the
three
months ended in Dec. 2024 was $0.04.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was $0.10.
During the past 12 months, InfuSystems Holdings's average EPS without NRIGrowth Rate was 175.00% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 22.40% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -26.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, InfuSystems Holdings's highest 3-Year average EPS without NRI Growth Rate was 22.40% per year. The lowest was -75.70% per year. And the median was -59.55% per year.
InfuSystems Holdings EPS (Diluted) Historical Data
The historical data trend for InfuSystems Holdings's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of InfuSystems Holdings's EPS (Diluted)
For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings's PE Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's PE Ratio distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's PE Ratio falls into.
InfuSystems Holdings EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
InfuSystems Holdings's Diluted EPS for the fiscal year that ended in Dec. 2024 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.10
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
InfuSystems Holdings EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of InfuSystems Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INFU has been successfully added to your 